Stress Urinary Incontinence (Male)
At a glance
- Assess: confirm stress versus urgency/overflow leakage, quantify pads or pad weight and bother, review prostate treatment/radiation, examine the stress leak, and evaluate urine and emptying. Perform cystourethroscopy before an SUI operation; use urodynamics selectively when it can clarify diagnosis or counselling.[4]
- Options: PFMT and containment while recovery continues. For bothersome SUI that is not improving, surgery may be offered from 6 months and should be offered at 1 year despite conservative treatment. Discuss sling for selected mild–moderate disease and AUS across the severity range.[4]
- Reconsider the pathway: address obstruction, infection and unsafe storage before implanting. Radiation favours AUS over sling; confirm physical and cognitive ability to operate the pump. Bulking has low efficacy and cure is rare.[4]
- Follow-up: track bother, leakage and emptying, including urgency that persists despite stress-leak improvement. Discuss device erosion, infection and future revision; suspected device complications or recurrent obstruction need assessment.[4]
Compare MASTER outcomes: improvement and satisfaction are not the same as complete dryness.
Male stress urinary incontinence (SUI) is involuntary urine loss with physical exertion, cough, sneeze, or Valsalva. In contemporary reconstructive practice it is overwhelmingly an incontinence-after-prostate-treatment problem: radical prostatectomy, radiation, and outlet surgery can injure the external rhabdosphincter, bladder-neck support, periurethral tissues, and pelvic innervation.[1][2][3] The AUA/GURS/SUFU Incontinence After Prostate Treatment guideline anchors contemporary evaluation, counseling, and procedural selection.[4]
This page covers the clinical framework — who has it, how to grade it, when to intervene. For the operative options and selection criteria, see the Male SUI treatment database.
Epidemiology and Etiology
Post-prostatectomy (the dominant cause)
After radical prostatectomy, reported SUI prevalence spans a wide range depending on definition, follow-up, and measurement method — 5–60% at 3–6 months, with most resolving by 12 months.[1][2][5] Persistent incontinence beyond one year affects roughly 5–20% of post-RP patients in modern cohorts.[4][6]
Risk factors for persistent post-RP SUI:[4][6]
- Advancing age
- Higher BMI
- Preoperative LUTS / baseline urethral function
- Longer membranous urethral length on preoperative MRI (protective)
- Nerve-sparing status
- Surgeon volume and technique
- Prior or subsequent radiation therapy
Other causes
- TURP / HoLEP / other BPH surgery — SUI is uncommon but clinically important when apical resection, prior radiation, or sphincter injury compromises the external sphincter.[4]
- Pelvic trauma — external urethral sphincter damage with pelvic fracture urethral injury
- Neurogenic — lesions of the thoracolumbar sympathetic outflow (T11–L2) impair proximal urethral tone; sacral lesions (S2–S4) affect the rhabdosphincter; pelvic plexus destruction, cauda equina compression, and selected spinal cord lesions can similarly unmask sphincteric leakage.[7]
- Post-cystectomy neobladder — continence depends on an intact external sphincter; SUI here is a distinct problem from reservoir function
Pathophysiology
Male SUI is fundamentally an intrinsic sphincter deficiency (ISD) problem.[1][2] After prostatectomy, three mechanisms compound:
- Direct rhabdosphincter injury during apical dissection
- Loss of the proximal continence mechanism — bladder neck and prostatic urethra no longer contribute
- Local denervation from pelvic plexus or pudendal-branch injury
Radiation adds progressive fibrosis of the membranous urethra, stiffens the sphincter, and over years can convert a well-compensated patient into a leaker.
Detrusor overactivity, impaired compliance, and bladder-neck contracture can coexist with sphincter deficiency and produce a mixed incontinence picture. The reconstructive consequence is practical: bladder-only management rarely resolves leakage with a sphincteric driver, and sling or AUS planning is unsafe until obstruction, poor compliance, infection, and dominant urgency symptoms have been addressed.[4][6]
Diagnosis and Evaluation
Initial workup
- History — onset relative to surgery, pad count (pads-per-day, PPD), pad weight, activities that provoke leakage, nocturnal vs daytime distribution, prior radiation, comorbidities, medications
- Validated instruments — ICIQ-SF, UDI-6, IPSS for mixed LUTS[4]
- 3-day voiding diary with pad weights
- Physical exam — standing cough stress test, perineal sensation, anal tone, DRE (post-RP anatomy)
- Urinalysis + culture to rule out UTI
- Post-void residual — bladder US or catheter
- 24-hour pad test — preferred objective severity measure before surgery[4]
See Assessment Tools & Questionnaires for instrument detail.
Specialized evaluation
Before an SUI operation, assess urethral integrity and whether further functional testing will change management:[4][6]
- Urodynamics — use selectively to clarify the cause of leakage, storage safety or emptying dysfunction and inform counselling; not mandatory for every patient
- Cystoscopy — bladder neck contracture, vesicourethral anastomotic stricture, urethral stones; bladder neck contracture is a critical pre-surgical finding because it must be treated before sling or AUS
- MRI (selected) — membranous urethral length if planning anatomic sling
Red flags deserving expedited referral: gross hematuria, new obstructive symptoms, recurrent UTIs, suspected fistula.
Severity grading
Pad count and weight help describe severity, but these practical bands are not validated universal thresholds. Pad type, activity and patient bother also matter:[4][8]
| Severity | Pads/day | 24-h pad weight | Typical surgical option |
|---|---|---|---|
| Mild | 1–2 PPD | <100 g | Observation, sling or AUS after counselling |
| Moderate | 3–5 PPD | 100–400 g | Sling or AUS (patient preference; radiation favors AUS) |
| Severe | >5 PPD, continuous leak | >400 g | AUS |
Radiation history shifts selection toward AUS at any severity because radiated tissue is a poor sling bed and a high-risk erosion environment.
Natural History and Timing of Intervention
Post-RP SUI follows a predictable recovery curve. The AUA/GURS/SUFU guideline and contemporary series support:[4][5][6]
- Early recovery: offer pelvic floor exercises/training and symptom support; document the recovery trajectory.[9]
- From 6 months: surgery may be offered for bothersome SUI that is not improving despite conservative treatment.
- At 1 year: offer surgical treatment for bothersome persistent SUI despite conservative care; continued observation remains a patient choice.
A minority of men with severe persistent early SUI (e.g., continuous leakage at 6 months with no improvement trajectory) warrant earlier formal evaluation. The guideline emphasizes shared decision-making and bounds rather than rigid timelines.[4]
Management
Conservative (first 6–12 months)
- Pelvic floor muscle training — first-line; Cochrane evidence supports possible benefit, but the certainty is limited by small heterogeneous trials and inconsistent PFMT protocols[9]
- Lifestyle — fluid and caffeine management, weight loss, smoking cessation
- Biofeedback-augmented PFMT — may accelerate learning but is not clearly superior to PFMT alone long-term[9]
- Electrical stimulation (surface, perineal, or anal stimulation) — evidence is mixed and generally low certainty; use as an adjunct rather than a substitute for supervised PFMT[10]
- Penile compression (clamp) — temporizing only; chronic use risks urethral erosion and skin necrosis
There is no FDA-approved drug specifically for male SUI. Duloxetine has been used off label with tolerability limitations; bladder medications target coexisting urgency and do not repair sphincter injury. See the duloxetine hub for its evidence and prescribing status.[6]
Surgical options — overview
Treatment selection integrates severity, radiation history, urethral and cognitive factors, and patient preference. For detailed selection criteria and outcomes see the Male SUI treatment database. These are choices, not a mandatory escalation sequence:
| Option | Best candidate | Key consideration |
|---|---|---|
| Urethral bulking | Mild, patient declining sling/AUS | Low efficacy; cure is rare, and repeat treatment may be needed |
| Male urethral sling | Mild to moderate, no radiation, intact urethra | Passive, no device to operate; best outcomes in low pad-weight patients |
| Periurethral balloons (ProACT) | Selected mild-to-moderate SUI where available | Postoperative titration is the main draw; evidence and availability vary by region |
| Artificial urinary sphincter (AUS) | Mild through severe; particularly radiation or higher severity | Gold standard — durable efficacy; patient must be able to operate the pump |
Historical autologous fascial slings and Burch-style suspensions have been largely replaced by the options above, though the principle of compression/support under the bulbar urethra persists.[2][11]
Outcomes
| Intervention | Key outcome | Reference |
|---|---|---|
| PFMT | May hasten early continence recovery after prostate surgery; certainty remains limited by trial heterogeneity | Johnson Cochrane 2023[9] |
| Urethral sling | Best outcomes in non-irradiated mild-to-moderate SUI; failure risk rises with high pad weight, prior radiation, and poor urethral mobility | Sandhu 2010; Prebay 2023[2][11] |
| AUS | Most durable option for moderate-to-severe post-prostate-treatment SUI; revisions are expected over long follow-up | AUA/GURS/SUFU 2024; Sandhu 2010[4][2] |
| Bulking | Low efficacy and rare cure; not a routine substitute for sling or AUS | AUA 2024 and older limited comparative evidence[4][12] |
Radiation degrades outcomes across every modality; AUS in the radiated patient has higher erosion and revision rates but remains the most effective option.
Complications to Counsel
AUS-specific: mechanical failure, cuff erosion (higher with radiation), infection requiring explant, atrophy requiring downsizing or reposition, need for patient dexterity to cycle the pump.
Sling-specific: perineal pain, inability to catheterize in retention, sling release if obstructive, mesh-related complications (rare but present).
Bulking-specific: migration, repeat injections, limited durability.
Shared: urinary retention, UTI, de novo or persistent overactive bladder symptoms.
Selected evidence
MASTER · 2021[13]. The comparison below preserves the study-specific population, denominator, endpoint and uncertainty.
Selected studies, not a systematic review. Outcomes and populations differ; percentages across studies should not be ranked as if they were directly comparable. These source checks do not record a clinician review of the full article.
| Study and population | Comparison and results | Use and limitations |
|---|---|---|
| MASTER · 2021 Men with bothersome urodynamic stress incontinence after prostate surgery at 27 UK centres. Randomized n=380 | Transobturator male sling vs artificial urinary sphincter (AUS) Any patient-reported leakage (strict continence definition) · 12 months Still incontinent: 134/154 (87.0%) with sling vs 133/158 (84.2%) with AUS. Both groups improved symptom scores. Noninferiority established against a 15-percentage-point margin (P=.003); this is not proof of equivalent dryness. ICIQ-UI symptom score · 12 months 8.7 with sling vs 7.5 with AUS (lower is better). Adjusted mean difference 1.4; 95% CI 0.2–2.6; statistically different secondary outcomes favoured AUS. | Both can improve symptoms. Select using severity, radiation history, urethral status and ability to operate an AUS.
|
See Also
- Male SUI treatment database
- Artificial Urinary Sphincter
- Male Urethral Slings
- Pelvic Floor Physical Therapy
- Assessment Tools & Questionnaires
- Stress Urinary Incontinence (Female)
References
1. Koch GE, Kaufman MR. "Male Stress Urinary Incontinence." Urol Clin North Am. 2022;49(3):403-418. doi:10.1016/j.ucl.2022.04.005
2. Sandhu JS. "Treatment Options for Male Stress Urinary Incontinence." Nat Rev Urol. 2010;7(4):222-8. doi:10.1038/nrurol.2010.26
3. Radadia KD, Farber NJ, Shinder B, et al. "Management of Postradical Prostatectomy Urinary Incontinence: A Review." Urology. 2018;113:13-19. doi:10.1016/j.urology.2017.09.025
4. Breyer BN, Kim SK, Kirkby E, Marianes A, Vanni AJ, Westney OL. "Updates to Incontinence After Prostate Treatment: AUA/GURS/SUFU Guideline (2024)." J Urol. 2024;212(4):531-538. doi:10.1097/JU.0000000000004088
5. Sacco E, Prayer-Galetti T, Pinto F, et al. "Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up." BJU Int. 2006;97(6):1234-1241. doi:10.1111/j.1464-410X.2006.06185.x
6. Castellan P, Ferretti S, Litterio G, Marchioni M, Schips L. "Management of Urinary Incontinence Following Radical Prostatectomy: Challenges and Solutions." Ther Clin Risk Manag. 2023;19:43-56. doi:10.2147/TCRM.S283305
7. Ginsberg DA, Boone TB, Cameron AP, et al. "The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation." J Urol. 2021;206(5):1097-1105. doi:10.1097/JU.0000000000002235
8. Wolfe AR, Khouri RK Jr, Bhanvadia RR, et al. "Male stress urinary incontinence is often underreported." Can J Urol. 2021;28(2):10589-10594. PMID:33872555
9. Johnson EE, Mamoulakis C, Stoniute A, Omar MI, Sinha S. "Conservative Interventions for Managing Urinary Incontinence After Prostate Surgery." Cochrane Database Syst Rev. 2023;4:CD014799. doi:10.1002/14651858.CD014799.pub2
10. Berghmans B, Hendriks E, Bernards A, de Bie R, Omar MI. "Electrical Stimulation With Non-Implanted Electrodes for Urinary Incontinence in Men." Cochrane Database Syst Rev. 2013;(6):CD001202. doi:10.1002/14651858.CD001202.pub5
11. Prebay ZJ, Foss HE, Wang KR, Chung PH. "A narrative review on surgical treatment options for male stress urinary incontinence." Transl Androl Urol. 2023;12(5):874-886. doi:10.21037/tau-22-629
12. Silva LA, Andriolo RB, Atallah ÁN, da Silva EM. "Surgery for Stress Urinary Incontinence Due to Presumed Sphincter Deficiency After Prostate Surgery." Cochrane Database Syst Rev. 2014;(9):CD008306. doi:10.1002/14651858.CD008306.pub3
13. Abrams P et al. Outcomes of a Noninferiority Randomised Controlled Trial of Surgery for Men with Urodynamic Stress Incontinence After Prostate Surgery (MASTER). 2021. doi:10.1016/j.eururo.2021.01.024.